| Literature DB >> 35610504 |
Martin Hohmann1,2, Ingo Ganzleben3,4, Alexander Grünberg5, Jean Gonzales-Menezes4, Florian Klämpfl5,3, Benjamin Lengenfelder5,3, Eva Liebing4, Christina Heichler4, Clemens Neufert4, Christoph Becker4, Markus F Neurath3,4, Maximilian J Waldner3,4, Michael Schmidt5,3.
Abstract
Multi- and hyperspectral endoscopy are possibilities to improve the endoscopic detection of neoplastic lesions in the colon and rectum during colonoscopy. However, most studies in this context are performed on histological samples/biopsies or ex vivo. This leads to the question if previous results can be transferred to an in vivo setting. Therefore, the current study evaluated the usefulness of multispectral endoscopy in identifying neoplastic lesions in the colon. The data set consists of 25 mice with colonic neoplastic lesions and the data analysis is performed by machine learning. Another question addressed was whether adding additional spatial features based on Gauss-Laguerre polynomials leads to an improved detection rate. As a result, detection of neoplastic lesions was achieved with an MCC of 0.47. Therefore, the classification accuracy of multispectral colonoscopy is comparable with hyperspectral colonoscopy in the same spectral range when additional spatial features are used. Moreover, this paper strongly supports the current path towards the application of multi/hyperspectral endoscopy in clinical settings and shows that the challenges from transferring results from ex vivo to in vivo endoscopy can be solved.Entities:
Mesh:
Year: 2022 PMID: 35610504 PMCID: PMC9130268 DOI: 10.1038/s41598-022-12794-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Schematics of the set-up (modified as described in our previous study[18]). The top schematic shows the overall set-up and the bottom schematic shows the optical set-up which images the light from the endoscope.
Centre wavelength for the MSI device.
| Wavelength in nm: | 396 | 438 | 475 | 512 | 542 | 575 | 628 |
| Colour | UV | Blue | Cyan | Teal | Green | Yellow | Red |
Figure 2Flowchart of the data analysis. It groups in the five steps: pre-processing, feature generation, feature reduction, classification and evaluation of the classifiers.
Figure 3Example of the Laguerre–Gaussian polynomials.
Figure 4Example of multispectral image for the different wavelength bands. An example for the labelling of this multispectral image is shown in Fig. 2.
Figure 5Example mouse image. The margin of the neoplastic lesion is marked in green.
Classification results of the tested classifiers for 25 mice with LOOS for the multispectral data set without (left side) and with spatial (right side) features.
| Method | ACC | ACC2 | AUC | MCC | ACC | ACC2 | AUC | MCC |
|---|---|---|---|---|---|---|---|---|
| Data set | Without spatial features | With spatial features | ||||||
| RF | 0.67 | 0.64 | 0.73 | 0.39 | 0.72 | 0.73 | 0.76 | 0.46 |
| RB | 0.70 | 0.72 | 0.76 | 0.44 | 0.72 | 0.73 | 0.76 | 0.47 |
| SVM (lin) | 0.60 | 0.60 | 0.65 | 0.20 | 0.66 | 0.65 | 0.66 | 0.31 |
| SVM (Gauss) | 0.62 | 0.67 | 0.68 | 0.34 | 0.63 | 0.65 | 0.68 | 0.31 |
| AB | 0.68 | 0.70 | 0.75 | 0.41 | 0.73 | 0.73 | 0.76 | 0.47 |
The PCA is done and 99% of the variance of the PCA is used.
Comparison with the results from other groups.
| Study/year | Spectral range (nm) | Ex vivo/in vivo | MCC | AUC | ACC |
|---|---|---|---|---|---|
| Baltusen et al.[ | 400–1000 | 0.50 | 0.81 | 0.74 | |
| Baltusen et al.[ | 900–1600 | 0.59 | 0.87 | 0.80 | |
| Baltusen et al.[ | 400–1600 | 0.83 | 0.98 | 0.91 | |
| Collins et al.[ | 500–1000 | 0.49 | 0.93 | – | |
| This study with spatial features | 400–630 | 0.47 | 0.76 | 0.73 |
Classification results of the tested classifiers for the spontaneous cancer model (left) for 14 mice and the inflammation driven cancer model (right) for 11 mice.
| Method | ACC | ACC2 | AUC | MCC | ACC | ACC2 | AUC | MCC |
|---|---|---|---|---|---|---|---|---|
| Cancer model | Spontaneous (n = 14) | Inflammation driven (n = 11) | ||||||
| RFW | 0.73 | 0.74 | 0.77 | 0.48 | 0.71 | 0.71 | 0.74 | 0.43 |
| RB | 0.72 | 0.74 | 0.77 | 0.48 | 0.72 | 0.72 | 0.76 | 0.45 |
| SVM (lin) | 0.65 | 0.64 | 0.65 | 0.30 | 0.68 | 0.66 | 0.68 | 0.32 |
| SVM (Gauss) | 0.62 | 0.63 | 0.66 | 0.27 | 0.64 | 0.67 | 0.70 | 0.36 |
| AB | 0.73 | 0.74 | 0.77 | 0.48 | 0.72 | 0.73 | 0.75 | 0.46 |
Classification results of the MCC for all five classifiers as a function of spatial features and if inflammation driven tumour models are used or not.
| Spatial features | No | Yes | No | Yes |
|---|---|---|---|---|
| Cancer model | Spontaneous (n = 14) | Inflammation driven (n = 11) | ||
| RFW | 0.41 | 0.48 | 0.37 | 0.43 |
| RB | 0.43 | 0.48 | 0.45 | 0.45 |
| SVM (lin) | 0.24 | 0.30 | 0.15 | 0.32 |
| SVM (Gauss) | 0.36 | 0.27 | 0.32 | 0.36 |
| AB | 0.41 | 0.48 | 0.41 | 0.41 |